TAOX
TAO Synergies Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.57
+12.01%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$13
- Revenue estimate
- $88.6K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.83
- EPS estimate
- -$13
- Revenue actual
- $88.6K
- Revenue estimate
- $88.6K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +91.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$13 | -$1.83 | Beat 85.65% | $88.6K |
| May 13, 2026 | -$13 | -$0.46 | Beat 96.39% | $388.8K |
| Aug 15, 2025 | — | -$11 | — | $4.0K |
| May 15, 2025 | — | $0.04 | — | — |
| Dec 31, 2024 | — | -$4.10 | — | — |
| Sep 30, 2024 | — | -$4.35 | — | — |
| Jun 30, 2024 | — | -$1.06 | — | — |
| Mar 31, 2024 | — | -$0.20 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026